Afif Ben Salah, Pierre A Buffet, Gloria Morizot, Nathalie Ben Massoud, Amor Zâatour, Nissaf Ben Alaya, . . . Max Grögl. (2009). WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: A phase 2, randomized, double blind, placebo controlled study. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationAfif Ben Salah, et al. WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania Major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study. Public Library of Science (PLoS), 2009.
MLA (9th ed.) CitationAfif Ben Salah, et al. WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania Major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study. Public Library of Science (PLoS), 2009.